Fujio Yasushi | 大阪大学 薬学研究科臨床薬効解析学分野
スポンサーリンク
概要
関連著者
-
Fujio Yasushi
Department of Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical S
-
Fujio Yasushi
Department Of Clinical Pharmacology And Pharmacogenomics Graduate School Of Pharmaceutical Sciences
-
Fujio Yasushi
大阪大学 薬学研究科臨床薬効解析学分野
-
Fujio Yasushi
Clinical Evaluation Of Medicines And Therapeutics Graduate School Of Pharmaceutical Sciences Osaka U
-
Fujio Yasushi
Department Of Cardiovascular Medicine Osaka University Graduate School Of Medicine
-
Azuma Junichi
Department of Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical S
-
Nonen Shinpei
Department of Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical S
-
Fujio Yasushi
Department Of Clinical Evaluation Of Medicines And Therapeutics Graduate School Of Pharmaceutical Sc
-
Yamamoto Isamu
Department of Biological Sciences, Faculty of Science, Hiroshima University
-
Izumi Masahiro
Department of Cardiology, Osaka Medical Center for Cancer and Cardiovascular Diseases
-
Maeda Makiko
Department of Clinical Evaluation of Medicines and Threpeutics, Graduate School of Pharmacuetical Sc
-
Maeda Makiko
Department Of Clinical Pharmacology And Pharmacogenomics Graduate School Of Pharmaceutical Sciences
-
Maeda Makiko
Department Of Clinical Evaluation Of Medicines And Threpeutics Graduate School Of Pharmacuetical Sci
-
Azuma Junichi
Clinical Pharmacology And Pharmacogenomics Graduate School Of Pharmaceutical Sciences Osaka Universi
-
Azuma Junichi
Department Of Clinical Evaluation Of Medicines And Therapeutics Graduate School Of Pharmaceutical Sc
-
Nonen Shinpei
Department Of Clinical Pharmacology And Pharmacogenomics Graduate School Of Pharmaceutical Sciences
-
Yamamoto Isamu
Deparment Of Biological Science Graduate School Of Science Hiroshima University
-
Izumi Masahiro
Department Of Cardiology Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Izumi Masahiro
Osaka Medical Center For Cancer And Cardiovascular Disease
-
Takihara Keiko
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine
-
FUNAMOTO Masanobu
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
LIU Jianmin
Department of Clinical Pharmacology and Pharmacogenomics, Graduate School of Pharmaceutical Sciences
-
MOTOMURA Takashi
Department of Internal Medicine, NTT West Osaka Hospital
-
IGARASHI Tsuyoshi
Department of Internal Medicine, NTT West Osaka Hospital
-
Funamoto Masanobu
Funamoto Clinic
-
Takihara Keiko
Department Of Molecular Medicine Osaka University Medical School
-
Azuma Junichi
Department Of Clinical Pharmacology And Pharmacogenomics
-
Izumi Masahiro
Department Of Molecular Medicine Osaka University Graduate School Of Medicine
-
Igarashi Tsuyoshi
Department Of Internal Medicine Ntt West Osaka Hospital
-
Liu Jianmin
Department Of Clinical Pharmacology And Pharmacogenomics Graduate School Of Pharmaceutical Sciences
-
Funamoto Masanobu
Department Of Molecular Medicine Osaka University Graduate School Of Medicine
-
Takihara Keiko
Department Of Molecular Medicine Osaka University Graduate School Of Medicine
-
Motomura Takashi
Department Of Internal Medicine Ntt West Osaka Hospital
-
Azuma Junichi
Department Of Clinical Evaluation Of Medicines And Therapeutics Graduate School Of Pharmaceutical Sc
-
Funamoto Masanobu
Department Of Molecular Medicine Osaka University Medical School
-
Yamamoto Isamu
Department Of Clinical Pharmacology And Pharmacogenomics Graduate School Of Pharmaceutical Sciences
-
Fujio Yasushi
Department Of Clinical Pharmacology And Pharmacogenomics Graduate School Of Pharmaceutical Sciences
-
Fujio Yasushi
Department Of Clinical Pharmacology And Pharmacogenomics Graduate School Of Pharmaceutical Sciences
-
Takihara Keiko
Department Of Cardiovascular Medicine Graduate School Of Medicine University Of Tokyo
著作論文
- Adrenergic β_1 Receptor Polymorphism (Ser49Gly) Is Associated with Obesity in Type II Diabetic Patients(Miscellaneous)
- IS099 Activation of Signal Transducer and Activator of Transcription 3 is Required for gp130-mediated Induction of Vascular Endothelial Growth Factor in Cardiac Myocytes